ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Safety assessment of Neulasta® (pegfilgrastim) in patients with solid tumors: a real-world adverse event analysis from the FAERS database.
Keyun Lin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.